Quick Nav


Videos RSS Feed
January 22, 2014
Mary Lynn McPherson, PharmD, explains how rescheduling hydrocodone combination products as Schedule II drugs will help reduce levels of abuse.
January 21, 2014
Jeff Fudin, PharmD, FCCP, argues that studies comparing the abuse liability of hydrocodone combination products with that of other opioids have produced conflicting results.
January 20, 2014
Mary Lynn McPherson, PharmD, discusses why hydrocodone combination products were categorized as Schedule III in the first place.
January 16, 2014
Jeff Fudin, PharmD, FCCP, argues that categorizing hydrocodone combination products as Schedule II drugs is unlikely to reduce abuse of the medications.
January 16, 2014
Researchers discuss their study of COPD patients who have experienced a first myocardial infarction and the impact of beta-blocker therapy on mortality.
January 16, 2014
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.
January 16, 2014
Martin R. Stämpfli, PhD, explains the development of COPD in his lecture at the seminar “COPD—Bridging the Gap between Science and Clinical Care.”
January 14, 2014
An overview of “Get with the Guidelines – AFIB,” a quality-improvement program created by the American Heart Association for health care providers.
January 14, 2014
Christian Ruff, MD, MPH, gives an overview of the anticoagulants currently available for prevention of stroke in patients with atrial fibrillation.
January 14, 2014
Chris Cannon, MD, FACC, discusses 3 research papers on atrial fibrillation in this video produced by the American College of Cardiology.
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.

Become a Member
Forgot Password?